Skip to main content

Advertisement

SpringerLink
Log in

A population-based study on the prevalence and incidence of chronic kidney disease in the Netherlands

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Because most population-based studies on the epidemiology of chronic kidney disease (CKD) are cross-sectional, there is, except for end-stage renal disease, hardly any information on incidence rates.

Methods

We conducted a retrospective cohort study in a dynamic population, using data of 784,563 adult participants retrieved from the Integrated Primary Care Information database, a primary care database containing the complete electronic longitudinal medical records. CKD (both incidence and prevalence) was based on (1) an increased urine albumin-to-creatinine ratio, (2) a decreased estimated glomerular filtration rate, or (3) explicit statement in the medical record. Results were stratified by age according to the WHO standard population, sex, and diabetes mellitus.

Results

Based on a single measurement only, the incidence rate of CKD in adults was 1,213 per 100,000 person-years, and 6.7 percent of the adult population had a prevalent diagnosis of CKD. The incidence rate increased by age and was the highest in participants with diabetes with an incidence of 25,000 per 100,000 person-years, affecting over 75 percent of participants with diabetes.

Conclusions

This is the first study to report the incidence rates of all stages of CKD for the entire adult population, stratified by sex, 5-year age groups, and diabetes. Our data demonstrate that the incidence of CKD increases with age and is the highest in participants with diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. McClellan W et al (2006) Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol 17(6):1710–1715

    Article  PubMed  Google Scholar 

  2. Zhang QL, Rothenbacher D (2008) Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8:117

    Article  PubMed Central  PubMed  Google Scholar 

  3. Hallan SI et al (2006) International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17(8):2275–2284

    Article  PubMed  Google Scholar 

  4. Strandhagen E et al (2010) Selection bias in a population survey with registry linkage: potential effect on socioeconomic gradient in cardiovascular risk. Eur J Epidemiol 25(3):163–172

    Article  PubMed  Google Scholar 

  5. Collins G, Altman D (2012) Predicting the risk of chronic kidney disease in the UK: an evaluation of QKidney(R) scores using a primary care database. Br J Gen Pract 62(597):e243–e250

    Article  PubMed Central  PubMed  Google Scholar 

  6. Drey N et al (2003) A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 42(4):677–684

    Article  PubMed  Google Scholar 

  7. Tohidi M et al (2012) Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS One 7(9):e45304

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Nagai K et al (2013) Annual incidence of persistent proteinuria in the general population from Ibaraki annual urinalysis study. Clin Exp Nephrol 17(2):255–260

    Google Scholar 

  9. Liu JH et al (2012) The risk for chronic kidney disease in patients with heart diseases: a 7-year follow-up in a cohort study in Taiwan. BMC Nephrol 13:77

    Article  PubMed Central  PubMed  Google Scholar 

  10. Butt AA, Wang X, Fried LF (2011) HCV infection and the incidence of CKD. Am J Kidney Dis 57(3):396–402

    Article  PubMed  Google Scholar 

  11. Evans K et al (2011) Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrol Dial Transplant 26(3):899–908

    Article  PubMed Central  PubMed  Google Scholar 

  12. Zoppini G et al (2009) Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 19(8):580–586

    Article  CAS  PubMed  Google Scholar 

  13. Yamagata K et al (2007) Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 71(2):159–166

    Article  CAS  PubMed  Google Scholar 

  14. Nitsch D et al (2013) Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ 346:f324

    Article  PubMed Central  PubMed  Google Scholar 

  15. Go AS et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305

    Article  CAS  PubMed  Google Scholar 

  16. Roderick PJ et al (2009) CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 53(6):950–960

    Article  PubMed  Google Scholar 

  17. Nitsch D et al (2011) CKD and hospitalization in the elderly: a community-based cohort study in the United Kingdom. Am J Kidney Dis 57(5):664–672

    Article  PubMed Central  PubMed  Google Scholar 

  18. Kerr M et al (2012) Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant 27(3 Suppl):Iii73–Iii80

    PubMed Central  PubMed  Google Scholar 

  19. Fox CS et al (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 380(9854):1662–1673

    Article  PubMed Central  PubMed  Google Scholar 

  20. Naud J et al (2012) Current understanding of drug disposition in kidney disease. J Clin Pharmacol 52(1 Suppl):10S–22S

    Article  CAS  PubMed  Google Scholar 

  21. Mahmoodi BK et al (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 380(9854):1649–1661

    Article  PubMed  Google Scholar 

  22. Ahmad OB, et al. (2001) Age standardization of rate: a new WHO standard. [cited 2013 21 Feb 2013]; Available from: http://www.who.int/healthinfo/paper31.pdf

  23. De Grauw WJC, K.H., Bilo HJG, Faber EF, Flikweert S†, Gaillard CAJM, Labots-Vogelesang SM, Verduijn MM, Verstappen WHJM, Vleming LJ, Walma EP, Van Balen, JAM. (2009) Landelijke Transmurale Afspraak Chronische nierschade (National Interdisciplinary Referral Agreement Chronic Kidney Disease). Huisarts en Wetenschap (12): pp. 586–597

  24. Vlug AE et al (1999) Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med 38(4–5):339–344

    CAS  PubMed  Google Scholar 

  25. van der Lei J et al (1993) The introduction of computer-based patient records in The Netherlands. Ann Intern Med 119(10):1036–1041

    Article  PubMed  Google Scholar 

  26. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002. 39(2 Suppl 1): p. S1–266

    Google Scholar 

  27. Levey AS et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612

    Article  PubMed Central  PubMed  Google Scholar 

  28. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009(113): pp S1–130

  29. Hvidberg E, Andersen AH (1980) New classification of drugs. The Medical list and the Drug catalogue are introduced in Anatomical–Therapeutic–Chemical classification code (ACT-code) in 1981. Ugeskr Laeger 142(6):396–397

    CAS  PubMed  Google Scholar 

  30. Rothman KJGS (1998) Modern epidemiology, 2nd edn. Lipincott and W.a.W, Philadelphia

    Google Scholar 

  31. Population WS; Available from: http://www.who.int/healthinfo/paper31.pdf

  32. Stevens LA et al (2010) Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant 25(2):449–457

    Article  PubMed Central  PubMed  Google Scholar 

  33. Camargo EG et al (2011) The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individuals. Diabet Med 28(1):90–95

    Article  CAS  PubMed  Google Scholar 

  34. Drion I et al (2011) The Cockcroft-Gault: a better predictor of renal function in an overweight and obese diabetic population. Obes Facts 4(5):393–399

    Article  CAS  PubMed  Google Scholar 

  35. Iliadis F et al (2011) Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations? Diabetologia 54(12):2987–2994

    Article  CAS  PubMed  Google Scholar 

  36. Nair S, Hardy KJ, Wilding JP (2011) The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula performs worse than the Modification of Diet in Renal Disease (MDRD) equation in estimating glomerular filtration rate in Type 2 diabetic chronic kidney disease. Diabet Med 28(10):1279

    Article  CAS  PubMed  Google Scholar 

  37. Rognant N et al (2011) Performance of the chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in diabetic patients. Diabetes Care 34(6):1320–1322

    Article  PubMed Central  PubMed  Google Scholar 

  38. Silveiro SP et al (2011) Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation pronouncedly underestimates glomerular filtration rate in type 2 diabetes. Diabetes Care 34(11):2353–2355

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Trimarchi H et al (2012) Creatinine- vs. cystatin C-based equations compared with 99mTcDTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease. J Nephrol 25(6):1003–1015

    Article  CAS  PubMed  Google Scholar 

  40. Viktorsdottir O et al (2005) Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults. Nephrol Dial Transplant 20(9):1799–1807

    Article  PubMed  Google Scholar 

  41. Coresh J et al (2005) Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16(1):180–188

    Article  PubMed  Google Scholar 

  42. Nitsch D et al (2006) Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study. Nephrol Dial Transplant 21(4):935–944

    Article  PubMed  Google Scholar 

  43. Cirillo M et al (2006) Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int 70(4):800–806

    Article  CAS  PubMed  Google Scholar 

  44. Brown WW et al (2003) Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 42(1):22–35

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Medical Informatics, Erasmus Medical Center, Room Ee2116, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands

    Jan C. van Blijderveen, Sabine M. Straus, Bruno H. Stricker, Miriam C. Sturkenboom & Katia M. Verhamme

  2. Dutch Medicines Evaluation Board, Utrecht, The Netherlands

    Jan C. van Blijderveen & Sabine M. Straus

  3. Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands

    Robert Zietse

  4. Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands

    Jan C. van Blijderveen, Bruno H. Stricker & Miriam C. Sturkenboom

  5. Drug Safety Unit, Inspectorate of Healthcare, The Hague, The Netherlands

    Bruno H. Stricker

Authors
  1. Jan C. van Blijderveen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sabine M. Straus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Zietse
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bruno H. Stricker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Miriam C. Sturkenboom
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Katia M. Verhamme
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan C. van Blijderveen.

Additional information

The first author works for the Medicine Evaluation Board, the drug regulatory agency in the Netherlands.

The views expressed in this article are the personal view of the author and may not be understood or quoted as being made on behalf of or reflecting the position of the regulatory agency.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 87 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Blijderveen, J.C., Straus, S.M., Zietse, R. et al. A population-based study on the prevalence and incidence of chronic kidney disease in the Netherlands. Int Urol Nephrol 46, 583–592 (2014). https://doi.org/10.1007/s11255-013-0563-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-013-0563-3

Keywords

Search

Navigation